Rendering of molecules

Posters & Publications

Posters and Presentations
Poster Presentation – Pooled Fluorescein Staining Results from Two Dry Eye Disease Trials with Reproxalap, a Novel RASP Modulator for the Treatment of Dry Eye Disease
Association for Research in Vision and Ophthalmology (May 2026)
Posters and Presentations
Poster Presentation – Pooled Conjunctival Redness Data from 2 Dry Eye Chamber Trials with Reproxalap, a Novel RASP inhibitor for Treatment of Dry Eye Disease
American Society of Cataract and Refractive Surgery (April 2026)
Scientific Paper
Phase 3 Randomized Clinical Trial Evaluating the Safety of Reproxalap in Patients With Dry Eye Disease
Ophthalmology and Therapy (April 2026) Nathan M Radcliffe, John Sheppard, Blake Simmons, Desiree Owen, Ashley Nguyen, Bill Cavanagh, Todd C Brady
Posters and Presentations
Poster Presentation – Reproxalap Acutely Reduces Ocular Discomfort in Phase 3 Dry Eye Disease Chamber Trial (American Society of Cataract and Refractive Surgery 2026)
American Society of Cataract and Refractive Surgery (April 2026)
Posters and Presentations
Poster Presentation – Efficacy and Safety of 0.25 Reproxalap Ophthalmic Solution in Patients With Dry Eye Disease Results From a Dry Eye Chamber Trial
Southeastern Educational Congress of Optometry (February 2026)
Posters and Presentations
Poster Presentation – Reproxalap Exhibits No Safety Concerns and Statistical Significantly Improves Vision in a Pivotal Dry Eye Disease Safety Trial (American Academy of Ophthalmology 2025)
American Academy of Ophthalmology (October 2025)
Posters and Presentations
Poster Presentation – Pooled Safety and Efficacy Analysis From Two 12-Week Reproxalap Dry Eye Disease Trials
American Academy of Ophthalmology (October 2025)
Scientific Paper
Reproxalap Improves Ocular Redness, Tear Production, and Symptoms in a Pivotal Dry Eye Disease Chamber Trial
Ophthalmology Science (September 2025) Sumit Garg, Eric Donnenfeld, John Sheppard, Alice Epitropoulos, Todd C Brady
Scientific Paper
The Phase 3 INVIGORATE Trial of Reproxalap in Patients with Seasonal Allergic Conjunctivitis
CLINICAL OPHTHALMOLOGY (December 2023) Christopher E. Starr, Kelly K. Nichols, Jacob R. Lang, Todd C Brady
Posters and Presentations
Poster Presentation – The Novel RASP Modulator Reproxalap Rapidly Improves Signs and Symptoms of Dry Eye Disease: The TRANQUILITY Run In Cohort
April 2022